Tumours classified as "malignant histiocytosis" in children are T-cell neoplasms.
During the last five years increasing evidence has accumulated that many tumours classified as 'histiocytic' in the past do not originate from macrophages, but from transformed (or anaplastic) large lymphoid cells. Most of these studies have focused upon adult neoplasms. Knowledge concerning the lineage of 'histiocytic' tumours in the paediatric age group is more limited. In this study we have examined the clinical, morphological and immunophenotypical features of six childhood malignancies originally diagnosed as being of histiocytic origin. Three patients showed an aggressive course with involvement of internal organs and very short survival times. Two patients were brought into remission: one is alive without active disease after seven years; the other died after seven years due to treatment-related cardiomyopathy. The remaining patient had a protracted course for two and a half years, but subsequently deteriorated and died three years after diagnosis. The histomorphological features in five cases were those of anaplastic large cell lymphomas. The remaining case consisted of pleomorphic (rather than anaplastic) large lymphoid cells. In all cases the immunophenotypical examination showed features characteristic of activated T lymphocytes. All cases were positive for Ki-1 (CD30), and three were positive for epithelial membrane antigen (EMA). Histiocyte-associated markers were positive in residual reactive macrophages, but nowhere could unequivocal positivity for macrophage-associated markers be seen in the neoplastic cells. It is concluded that most childhood malignancies in the past classified as 'histiocytic' are examples of anaplastic large cell (Ki-1) lymphomas of T-cell type and that true histiocytic malignancies are exceedingly rare in the paediatric age group.
Ornvold
K
K
Laboratory of Paediatric Pathology, Rigshospitalet, University of Copenhagen.
Carstensen
H
H
Junge
J
J
Gyhrs
A
A
Ralfkiaer
E
E
D015703:Antigens, CD / Q000032:analysis; D000951:Antigens, Neoplasm / Q000032:analysis; D002648:Child; D002675:Child, Preschool; D005260:Female; D054747:Histiocytic Sarcoma / Q000145:classification* / Q000276:immunology / Q000473:pathology; D006801:Humans; D016130:Immunophenotyping; D007223:Infant; D017730:Ki-1 Antigen; D016403:Lymphoma, Large B-Cell, Diffuse / Q000145:classification* / Q000276:immunology / Q000473:pathology; D016399:Lymphoma, T-Cell / Q000145:classification* / Q000276:immunology / Q000473:pathology; D008297:Male; D008562:Membrane Glycoproteins / Q000032:analysis; D018396:Mucin-1
D015703:Antigens, CD; D000951:Antigens, Neoplasm; D017730:Ki-1 Antigen; D008562:Membrane Glycoproteins; D018396:Mucin-1